FDA advisory committee

liver

Ocaliva's fate looks bleak after FDA releases new briefing docs

For Intercept Pharmaceuticals’ beleaguered liver disease drug Ocaliva, the hits just keep coming.

Fraiser Kansteiner Sep 11, 2024 4:58pm

FDA

With ODAC, FDA weighs limiting PD-1 drugs in stomach cancer

Aug 22, 2024 3:28pm

Imfinzi

Amid concerns, FDA approves AZ's Imfinizi in perioperative NSCLC

Aug 16, 2024 10:51am

Imfinzi

AZ set to face tough questions on Imfinzi expansion bid in NSCLC

Jul 24, 2024 8:29am

microscope

Novo Nordisk's weekly insulin will get FDA adcomm review

Apr 29, 2024 11:08am

Hand posing an envelop in a ballot box for elections

FDA advisers back new endpoint for myeloma approvals

Apr 12, 2024 4:06pm